In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory board member Robert L. Bard, MD, PC, DABR, FASLMS, discusses other advancements in diagnostic radiology and what new technologies are in development that could help in the fight against cancer.
Watch VIDEO PART I: Using 3-D Doppler Imaging and Other Advancements in Diagnostic Radiology
Dr. Bard is internationally known and recognized as a leader in his field. He specializes in advanced 3-D Doppler imaging to detect cancers in numerous organs, including the breast, prostate, and other areas. His images are used to accurately guide biopsies, target therapy and provide focused follow-up after treatment. He is committed to improving non-invasive cancer testing and developing minimally invasive image guided technologies to prevent cancer spread.
Watch VIDEO PART 2: VIDEO: The Advantages of Using Power Doppler Sonography on the Prostate to Screen for Tumors
In the spring of 2020, the Ellis Island Honor Society officially recognized Dr. Bard for his life’s work in clinical and research contributions in diagnostic imaging detection of cancers, which he received in person during a May 2022 ceremony, the prestigious 35th Annual Ellis Island Medal of Honor. Dr. Bard is also an Editorial Advisory Board Member for Imaging Technology News.
VIDEO: Using 3-D Doppler Imaging and Other Advancements in Diagnostic Radiology
VIDEO: The Advantages of Using Power Doppler Sonography on the Prostate to Screen for Tumors
One on One ... with Robert L. Bard, MD, PC, DABR, FASLMS
The Full Body Imaging Movement: A Strategic Upgrade of the MRI
Microcirculation and Electromagnetic Response to Inflammation
Carri Glide-Hurst, Ph.D., and Benjamin Movsas, M.D., discuss Henry Ford Hospital's involvement in a national clinical trial assessing the effectiveness of magnetic resonance imaging (MRI)-guided radiation therapy in pancreatic cancer.
Watch the related VIDEO: Clinical Use of the ViewRay MRIdian Linac System at Henry Ford — Interview with Benjamin Movsas, M.D.
Find more content on Henry Ford Hospital
Register to view a webinar on the ViewRay MRI-guided radiation therapy system.
Eric Morris, a Ph.D. candidate at Henry Ford Hospital and Wayne State University, explains his project to automate registration and segmentation of cardiac structures in treatment planning scans for breast cancer radiation therapy.
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Group and head of the Duke medical physics graduate program. He spoke on this topic at the American Association of Physicists in Medicine (AAPM) 2018 meeting.
A discussion with Kevin Moore, Ph.D., DABR, deputy director of medical physics and associate professor, University of California San Diego, about his daily clinical use of an artificial intelligence treatment planning software. He spoke on this at the American Association of Physicists in Medicine (AAPM) 2018 meeting.
Also watch the VIDEO: The Impact of Artificial Intelligence on Radiation Therapy — an interview with Steve Jiang, Ph.D.
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 American Association of Physicists in Medicine (AAPM) meeting.
Click here for more coverage of the 2018 AAPM annual meeting.
A discussion with Mahadevappa Mahesh, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and chief physicist at Johns Hopkins, Baltimore. He also serves as treasurer for the American Association of Physicists in Medicine (AAPM) and spoke to ITN at the 2018 meeting.
Watch the VIDEO Radiation Dose Monitoring in Medical Imaging, an interview with Mahesh at the 2016 Radiological Society of North America (RSNA) annual meeting.
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico. He spoke about his research using direct proton imaging on the treatment table without the need for other external or on-board imaging systems. He spoke at the 2018 American Association of Physicists in Medicine (AAPM) meeting.
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada. He spoke on this topic in sessions at the American Association of Physicists in Medicine (AAPM) 2018 meeting. He explains radiomics and how it can be used in both medical imaging and radiation therapy.
Read the related article "Hidden Information Behind Imaging Tests for Cancer May Unlock New Approaches to Radiation Therapy."
Read the related article "Computer Program Beats Physicians at Brain Cancer Diagnoses."
Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Group and head of the Duke medical physics graduate program, explained this new program at the American Association of Physicists in Medicine (AAPM) 2018 meeting.
A discussion with Steve Jiang, Ph.D., director of the medical artificial intelligence and automation lab and vice-chair of the Department of Radiation Oncology, University of Texas Southwestern. He spoke in sessions at AAPM 2018 about how AI will change treatment planning, radiation oncology and medical imaging.
Watch the VIDEO: Real-world Implementation of Deep Learning for Treatment Planning — a discussion with Kevin Moore, Ph.D., DABR, deputy director of medical physics and associate professor, University of California San Diego, about his daily clinical use of an artificial intelligence treatment planning software.
Other coverage from the AAPM 2018 meeting.
#AAPM2018
This is an example of how Cherenkov radiation glow can be collected with image intensifier cameras during radiotherapy to show the exact location of the beam and the amount of dose delivered. This can be used to quickly verify everything matches the treatment plan and dosimetry. This video was shot in the booth of DoseOptics at the 2018 American Association of Physicists in Medicine (AAPM). The company is developing this technology and hopes to submit it to U.S. Food and Drug Administration(FDA) for review in the next year.
Other coverage from the AAPM 2018 meeting.
#AAPM2018
American Association of Physicists in Medicine (AAPM) President Bruce Thomadsen, M.D., professor of medical physics at the University of Wisconsin, Madison, discusses the future direction of medical physics in a changing healthcare environment at the 2018 AAPM meeting.
Other coverage from the AAPM 2018 meeting.
#AAPM2018
Chris Toth, president, global commercial and field operations for Varian, takes a tour of Varian’s new product introductions and major initiatives highlighted at ASTRO 2017. These include:
• The Halcyon system, a new platform for cancer treatment that simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). Halcyon is a powerfully intuitive platform designed to help improve and strengthen the fight against cancer and enable access to high quality care anywhere in the world.
• The 360 Oncology care management platform, designed to integrate and coordinate patient care across the entire treatment and post-treatment journey. 360 Oncology brings together in a single platform, radiation, medical and surgical oncology, social services, primary care physicians, as well as the patient, to facilitate true collaboration and coordination.
• The latest release of Varian’s Eclipse treatment planning software, incorporating both Multi-Criteria Optimization (MCO) and Graphics Processing Unit (GPU) Support. MCO enables planners to look at tradeoffs in a treatment plan when different clinical criteria are varied, greatly enhancing control over optimization. GPU support decreases the dose calculation and inverse planning optimization times, providing a significant leap forward in speed.
• HyperArc high definition radiotherapy, technology that unlocks the potential of non-coplanar treatment strategies to usher in a new era of precision in the delivery of stereotactic radiosurgery (SRS).
For more information: www.varian.com
William Hall, M.D., radiation oncologist in the Department of Radiation Oncology at PeaceHealth St. Joseph Medical Center in Bellingham, Wash., discusses study results presented at theAmerican Society of Radiation Oncology (ASTRO) 2016. Video courtesy of Dr. Hall. You can read Dr. Hall's article on this topic, Breast Cancer Radiation Planning, here.
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains how research presented at the 2017 Annual Meeting was chosen to reflect new trends in radiation therapy.
Watch the VIDEO "The Future of Radiation Oncology"
Watch the VIDEO "Clinical Considerations for Proton Therapy"
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key themes of the 2017 Annual Meeting and the issues ASTRO will focus on going into 2018.
Watch the VIDEO "Inside the ASTRO Scientific Committee"
Watch the VIDEO "Clinical Considerations for Proton Therapy"
The new Visicoil MR is a helically-wound, flexible linear fiducial marker. The Visicoil MR hollow core design and multiple sizes mitigates the CT artifact often created by traditional gold seeds, offering you clearer visualization of the tissue to aid in faster and more accurate contouring. Visicoil MR's linear flexible design fixates and remains stable in soft tissue, giving you the confidence in accurate marker localization. Visicoil MR is available in some of the smallest needle sizes available for fiducial markers, including 21g and 22g needles. The benefits of smaller needles are improved patient safety and comfort during implantation. The smaller needles may also allow for faster CT sim after implant and ultimately treatment for your patients. The new Visicoil MR with enhanced MRI visibility allows you to see the marker more easily in MRI, both in T1 and T2. This makes for easier and faster MR/CT fusion.
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of the role of medical physics in healthcare and highlights the association's initiatives at the 2017 AAPM annual meeting in Denver.
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the clinical applications and practical aspects of operating a proton therapy center at the 2017 American Association of Physicists in Medicine (AAPM) annual meeting.
Join Chris Toth, president, Oncology Systems Americas, for a look at Varian’s new product introductions and major initiatives highlighted at ASTRO this year:
Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central database and the Cloud. It offers full support throughout all of your QA, and enables you access to the different software modules and all of your data from one intuitive interface – anywhere and anytime.
Accuray recently unveiled the company’s newest innovation, the Radixact Treatment Delivery System, a uniquely smart, fully integrated treatment delivery, treatment planning and data management system. Hear from the Accuray team about this new, next-generation TomoTherapy platform, as well as how recent innovations to the CyberKnife platform reduce treatment time while providing leading-edge motion tracking and real-time beam adjustment. Discover how Accuray systems can help clinicians deliver precise tumor treatments with confidence.
Rachael Bennett, clinical analyst for MD Buyline, discusses trends in radiation oncology at ASTRO 2016.
ASTRO Chairman of the Board David C. Beyer, MD, FASTRO, discusses the current trends in radiation oncology, key trends presented at this year's conference, and achieving value, and opportunities to improve value, in the treatment of prostate cancer.
Patient QA Efficiency with Dolphin presented at AAPM 2016 IBA booth. Dolphin Online Ready is released and in clinical use for pre-treatment QA.
AAPM President Bruce Curran, MEng, FAAPM, FACMP, FACR, discusses the key topics at the 2016 meeting of the American Association of Physicists in Medicine. Topics included the advancement of radiomics in medical imaging for quantification for evidence-based clinical decision making in cancer, and improving how quality assurance is done in radiation therapy.
At ASTRO 2015, Mevion highlighted the exceptional results its customers are seeing with the Mevion S250 Series proton therapy system.
Varian offered an overview of its new technology offerings at ASTRO 2015. These include advancements in analytics, treatment planning, adaptive therapy, clinical decision support and new tools for the integration of MRI and PET/CT into the treatment planning process.
Learn more about myQA, IBA’s unique platform that connects QA applications, people, and know-how through a central database and the Cloud. It offers full support throughout all of your QA, and enables you access to the different software modules and all of your data from one intuitive interface – anywhere and anytime.
This brief video highlights the grassroots effort from IBA Dosimetry to satisfy customers through value added services and benefits that continue throughout the life cycle of their products, and beyond.
Joseph Deasy, Ph.D., discusses his study on dose-volume relations for late rectal bleeding in 1,001 patients from five prostate cancer cohorts with Imaging Technology News Editorial Director Melinda Taschetta-Millane.
American Association of Physicists in Medicine (AAPM) President John Boone, Ph.D., discusses the impact of imaging in medical physics, as well as key topics addressed at this year’s meeting, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.
Detecting metastatic disease early is key. Sand Lake Imaging, Florida, provides great value to both patients and referrers by using syngo.via's efficient AV tools. See how!
The new syngo.via from Siemens Healthcare supports oncological treatment decisions across modalities, therapies and departments to enable state-of-the-art cancer care, increased competitiveness, and high referrer and patient satisfaction. syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right. syngo.via VB10 and the syngo.via VB10 based software options are currently under development, and not for sale in the U.S., China and other countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
Volpara now offers products to track breast density in mammography, X-ray radiation dose and analytical data. The company now integrates with tomosynthesis 3-D mammo systems. The technology has installations in 31 countries.
From the floor at this year's annual meeting of the American Society for Radiation Oncology (ASTRO), Chris Toth, vice president of global marketing and Americas sales at Varian Medical Systems, talks about the latest Varian technologies and how they can help enhance knowledge sharing among oncology care professionals. In the constantly evolving healthcare landscape, learn why Varian is developing leading edge solutions designed to help clinicians leverage data to improve the quality and consistency of care. Varian is creating a knowledge-based network, enabling clinical partners to share information, ideas, and best practices. Toth explains how InSightive Analytics, Varian's latest in a line of recently released informatics products, helps clinics dive deep into existing data in order to achieve actionable insights. Being able to explore, visualize, and aggregate critical data using InSightive can help improve operations as well as clinical care.
Suzanne Shankle, IBA product marketing specialist, explains how Dolphin helps provide better care and gives online control and confidence of treating patients safely.
Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of seconds, benefiting from the MEVION S250's direct and efficient beam generation. The result is a fast Pencil Beam Scanning enabling robust Intensity Modulated Proton Therapy treatment delivery that is much less sensitive to patient and tumor motions, ultimately increasing the efficacy of the treatment procedure. The MEVION S250 proton therapy platform with HYPERSCAN allows you to treat with precision, accuracy and reproducibility at unparalleled speed with uncompromised beam quality. Designed for greater access by any size cancer care facility, the MEVION S250 significantly reduces the complexity, size, and cost associated with conventional proton therapy systems. The MEVION S250 is specifically engineered as upgrade-ready to continue providing the most advanced proton therapy treatment available today as well as tomorrow. Key Features : Field-Upgradeable; Streamlined Clinical Workflow with Full OIS Integration; High-Accuracy Beam Pointing with Submillimeter Position Tracking; Fast Volumetric and Layer Rescanning Capabilities; Supports Standard Gating Interface for Beam On/Off Hold
Kettering's oncolcogy services worked with Elekta to provide the latest radiation therapy with the Veras HD system.
AAPM President John E. Bayouth, Ph.D., discusses the impact of imaging in medical physics, as well as training that is available through AAPM, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.